Evidence map›Paper›PMID 41679922›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026

PSMA PET/CT-Derived Indicators and Outcomes After [

Koichiro Kimura, Vishnu Murthy, Andrew F Voter, Lilja B Solnes, Abuzar Moradi Tuchayi, Surekha Yadav, Lela Theus, Andrew Nguyen, Vinicius Ludwig, Adrien Holzgreve and 6 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Baseline PSMA PET/CT Biomarkers for Patient Selection in [Pharmaceuticals (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Koichiro KimuraDepartment of Nuclear Medicine and Theranostics, Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, California; koichirokimura@mednet.ucla.edu.
Vishnu MurthyDepartment of Nuclear Medicine and Theranostics, Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, California.
Andrew F VoterDivision of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Lilja B SolnesDivision of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Abuzar Moradi TuchayiDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California.
Surekha YadavDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California.
Lela TheusDepartment of Nuclear Medicine and Theranostics, Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, California.
Andrew NguyenDepartment of Nuclear Medicine and Theranostics, Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, California.
Vinicius LudwigDepartment of Nuclear Medicine and Theranostics, Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, California.
Adrien HolzgreveDepartment of Nuclear Medicine and Theranostics, Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, California.
Lena M UnterrainerDepartment of Nuclear Medicine and Theranostics, Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, California.
Tristan R GroganDepartment of Medicine Statistics Core, David Geffen School of Medicine at UCLA, Los Angeles, California.
Johannes CzerninDepartment of Nuclear Medicine and Theranostics, Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, California.
Thomas A HopeDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California.
Andrei GafitaDivision of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Jeremie CalaisDepartment of Nuclear Medicine and Theranostics, Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, California.

Funding

UCLA SPORE in Brain CancerP50CA211015 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Yvonne Yu-Hsuan Chen · 2017 to 2026
$25.2M
NCI NIH HHS P50 CA211015
6 · The paper itself

Abstract

Pretherapeutic visual and quantitative indicators derived from prostate-specific membrane antigen (PSMA) PET/CT have been proposed as predictors of response to [

Indexed as

Antigens, SurfaceDipeptidesGlutamate Carboxypeptidase IIHeterocyclic Compounds, 1-RingLutetiumPositron Emission Tomography Computed TomographyProstatic Neoplasms, Castration-ResistantAgedAged, 80 and overHumansMaleMiddle AgedProstate-Specific AntigenRadioisotopesRetrospective StudiesTreatment OutcomeAntigens, SurfaceDipeptidesFOLH1 protein, humanGlutamate Carboxypeptidase IIHeterocyclic Compounds, 1-RingLutetiumLutetium-177Prostate-Specific AntigenPSMA-617Radioisotopes177Lu-PSMAimaging biomarkermetastatic castration-resistant prostate cancerPSMA PET/CTSUVmean

Identifiers

PMID41679922
PMCPMC13138095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.